The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making
process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Background and objective The clinical relevance of pleural effusions in lung cancer has
seldom been approached systematically. The aim of this study was to determine the …

Background Pleural effusion secondary to a nonmalignant cause can represent significant
morbidity and mortality. Nonmalignant pleural effusion (NMPE) is common, with congestive …

BACKGROUND The role of fluorodeoxyglucose (FDG)-PET imaging for diagnosing
malignant pleural effusions is not well defined. The aim of this study was to summarize the …

Pleural effusion is not a rare disease in Korea. The diagnosis of pleural effusion is very
difficult, even though the patients often complain of typical symptoms indicating of pleural …

Pleural effusions arise from a variety of systemic, inflammatory, infectious and malignant
conditions. Their precise etiological diagnosis depends on a combination of medical history …

BACKGROUND Chest CT scanning has become an integral part of the workup for
undiagnosed pleural effusions. We aimed to develop a CT scan-based scoring system for …

Pleural effusion (PE) is a key feature for a wide range of diseases. Although there are
dozens of documented causes of PE, only a few are responsible for most of the cases in …

Simple Summary Malignant pleural effusion is a common complication arising as the natural
progression of many tumors, such as lung cancer. When this occurs, the common protocol …